Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000495084 | SCV000578481 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000508235 | SCV000600740 | uncertain significance | not specified | 2017-06-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001474803 | SCV001678979 | likely benign | Hereditary breast ovarian cancer syndrome | 2022-07-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004023266 | SCV005029777 | likely benign | Hereditary cancer-predisposing syndrome | 2023-11-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |